Nucleotide sequences of field strains of foot and mouth disease virus (FMDV) contribute to our understanding of the distribution and evolution of viral lineages that circulate in different regions of the world. This paper outlines a practical reverse-transcription polymerase chain reaction (RT-PCR) and sequencing strategy that can be used to generate RNA sequences encoding the VP1 (1D) region of FMDV.
Introduction
Foot and mouth disease (FMD) is an economically important veterinary disease affecting multiple livestock species and leading to trade restrictions on animals and their products. Transmission of FMD between livestock can occur by a variety of mechanisms, including animal movement, through contaminated animal products (meat, milk, semen), mechanically by people and via other sources of fomites, and by the air (1) . Together, these factors contribute to the ease by which FMD can be spread across country borders and circumvent measures used for its control. 
Foot-and-mouth disease virus (FMDV) is the type species in the genus

Materials and methods
Samples
For this study, samples that were sequenced at The Pirbright Institute in the United Kingdom (UK), which is the World Reference
Laboratory for FMD (WRLFMD) and an OIE Reference Laboratory for FMD, were cell-culture-passaged isolates. However, samples that are rich in FMDV are also suitable for VP1 sequencing; these can be comprised of primary clinical material (such as vesicular fluid and vesicular epithelium). Recommended protocols for the collection of vesicular samples and the transport of this material to the laboratory have been described previously (14).
RNA Extraction
Total RNA was extracted from 460 μl of sample using the RNeasy kit (Table II) . A heated lid was used in order to minimise evaporation of the reaction liquid: alternatively, 50 μl of mineral oil (Promega) can be used to overlay the liquid in each tube. After the cycling programme was completed the tubes were held at 12°C until processed further.
Post polymerase chain reaction manipulations
The PCR products were analysed by electrophoresis on a 1.5%
agarose-Tris-borate-EDTA gel containing 1× GelRed nucleic acid stain (Biotium Inc, USA). DNA size markers (GeneRuler 100 bp DNA Ladder Plus, Fermentas Inc, USA) were run alongside the samples to quantify and confirm the correct size of the product (Table I) . Post-PCR removal of unincorporated nucleotides and primers was achieved using the illustra GFX PCR DNA and Gel Band
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Purification Kit (GE Healthcare Life Sciences, UK) according to the manufacturer's instructions. These products were eluted using 25 μl of elution buffer and the DNA content determined using a NanoDrop ND-1000 Spectrophotometer (Thermo Scientific, UK). In the event that multiple PCR amplicons were generated that could interfere with the sequencing, bands of the correct size were excised and purified (Qiagen).
Sequencing reactions
DNA sequencing of the PCR products was carried out using the BigDye® Terminator v3.1 Cycle Sequencing Kit (Life Technologies).
In a total volume of 10 µl, 2 µl 5× sequencing buffer was mixed with 0.5 µl BigDye® Terminator v3.1 (both reagents are supplied with the kit), 3 µl of appropriate sequencing primer (1.6 pmol) (Table III) n = 24 and SAT 3: n = 8) ( Table IV) . The criteria for selecting and designating prototype sequences for this list were principally, i) being the earliest example of each topotype and/or ii) being a laboratory reference strain. Over the past 10 years, the technical protocol for RT-PCR amplification and subsequent sequencing of the VP1 (1D) region of FMDV used at the FAO WRLFMD has generated sequence data for more than 4,500 virus isolates and field samples (individual reports can be accessed at www.wrlfmd.org/fmd_genotyping/). In all cases, at least one of the RT-PCR primer sets produced a specific amplicon from which the VP1 sequence was determined.
The choice of primers for VP1 RT-PCR is usually guided by prior knowledge of the serotype of the samples analysed. However, due to high genetic variability within the capsid-coding sequence of samples belonging to different FMDV serotypes, the primers are designed to target a broad range of genetically distant sequences. Therefore, these primers are not necessarily serotype specific and, due to possible cross-serotype amplification, they cannot be used for virus serotyping.
However, sequencing of the amplicon and comparison with the prototype sequences can be used for correct FMDV type identification. As non-homologous primer sets were not normally used, it was not possible to determine the frequency with which crossserotype amplification occurred.
This framework of prototype strains is a vital first step to harmonising the nomenclature used to describe and classify field strains of FMDV. 
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